SimpleScience@Heart Stem cell “homing” signal may help treat heart failure patients
In the first human study of its kind, scientists used gene therapy that acts like a “homing” signal for stem cells to treat heart failure patients.
The treatment involves injecting a gene for a naturally occurring protein called SDF-1. The protein is secreted by cells and guides the movement of other cells.
The study is unique because researchers introduced the “homing” factor to enhance the body’s natural repair process. Usually, scientists extract cells, multiply them, then deliver them back to the patient.
SDF-1 calls stem cells to an injured area to heal damaged tissue. But SDF-1 sends the signal for only about a week after a heart attack.
Researchers wanted to see if they could get SDF-1 to last longer — and they did! Up to a year after treatment, people who got the gene therapy could walk farther on a six-minute walk test and reported improved quality of life. Exams also showed that their hearts were pumping better.
If future trials of SDF-1 yield positive results, scientists say the treatment could be available to heart failure patients in four to five years.
Stories available for linking, quoting, excerpting, reprinting
Stories appearing on blog.heart.org under the "By American Heart Association News" byline are available for linking, quoting, excerpting and reprinting. Copyright is owned or held by the American Heart Association, Inc., and all rights are reserved. Permission is granted, at no cost and without need for further request, to link to, quote, excerpt or reprint from these stories in any medium as long as no text is altered and proper attribution is made to the American Heart Association. Additional conditions may apply to the use of these stories in printed materials.
American Heart Association additional conditions for linking, quoting, excerpting, reprinting stories in print media
- A credit line of American Heart Association News must be prominently placed on the page in which the American Heart Association materials appear.
- The American Heart Association logo and service marks may only be used if they appear on the materials requested.
- Stories reprinted may be edited for length, but no other deletions, alterations or other changes may be made without the prior written consent of the American Heart Association.
- Artwork labeled "American Heart Association" may be reprinted, but other artwork may not. For artwork permission questions, contact email@example.com
- Stories reprinted may not be placed adjacent to any advertisement, photo, graphic or other content that could be considered inappropriate by the American Heart Association. For questions about whether content is inappropriate, contact firstname.lastname@example.org.
- Stories may not be displayed in any way that gives the appearance that the American Heart Association endorses (implied or otherwise) or is affiliated with any product, service or company.